Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to ...

Samsung Bioepis has allegedly sub-licensed its Stelara biosimilar rights to a health conglomerate, breaching a previous ...

Johnson & Johnson (NYSE:JNJ) is suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's ...

Johnson & Johnson filed a lawsuit against Samsung Bioepis for allegedly breaching their agreement over the launch of ...

Johnson & Johnson is suing Samsung Bioepis for allegedly breaching the terms of a contract regarding the launch of the Korean ...

Here's a look at how weekly regional gas prices changed in Central Atlantic region last week compared with the week prior.

Applications are now open for grants from the Minnesota Department of Agriculture (MDA) to increase the competitiveness of ...

CIMA+, one of Canada's largest private consulting engineering firms, is pursuing its initiative to decarbonize and electrify ...

Last year marked an all-time record of 18 Food and Drug Administration (FDA) biosimilar approvals, bringing the total number ...

Canada's Marketing Hall of Legends, one of Canada's most respected and renowned industry awards, is proud to announce this ...

The new lower prices apply to some doses of Zepbound provided in vials but not the autoinjector pens.